United Therapeutics UTHR reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
United Therapeutics beat estimated earnings by 26.22%, reporting an EPS of $4.91 versus an estimate of $3.89.
Revenue was up $71.30 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $1.71 which was followed by a 3.14% drop in the share price the next day.
Here's a look at United Therapeutics's past performance:
| Quarter | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|
| EPS Estimate | 4.12 | 3.34 | 3.72 | 3.59 |
| EPS Actual | 2.41 | 5.03 | 3.51 | 4.16 |
| Revenue Estimate | 461.06M | 420.02M | 427.62M | 421.45M |
| Revenue Actual | 466.90M | 461.90M | 415.20M | 444.70M |
To track all earnings releases for United Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
